In the absence of prophylaxis, the occurrence of de novo hepatitis B is low in recipients who are anti-HBc positive/anti-HBs positive and high in patients with no prior contact with HBV who are not vaccinated (anti-HBc and anti-HBs negative).4 Here, KRT88P is linked to hepatitis B virus infection.